Pharmacy will never accept what industry lives with

March 29, 2019 Comment News of the Day

This is a preview of subscriber content

Subscribe now to continue reading.

The pharmaceutical industry is used to governments secretly seeking policy advice from the PBAC then presenting the outcome for consultation - pharmacy is not - as the government publishes the list of medicines it wanted subject to higher quantities. …

Subscribe now to continue reading.

Latest Video

Georgia Forrest

Sussan Ley's sometimes contentious but unquestionably consequential health legacy
February 15, 2026 - Latest News
PBS spending is driven less by explicit fiscal choices and more by the flow of recommendations
February 15, 2026 - Latest News
Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines
February 16, 2026 - Latest News
IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending
February 16, 2026 - Latest News
'It’s the first time in over 30 years that a new way of administering adrenaline has been approved in Australia'
February 16, 2026 - Latest News

Pharmacy will never accept what industry lives with

This is a preview of subscriber content

Latest Video

Most Read

Sussan Ley's sometimes contentious but unquestionably consequential health legacy

PBS spending is driven less by explicit fiscal choices and more by the flow of recommendations

Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines

IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending

'It’s the first time in over 30 years that a new way of administering adrenaline has been approved in Australia'

New Stories

Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines

Director pay rises across ASX healthcare sector, but gender balance remains uneven

Life sciences sector unites to advance women’s leadership at landmark 2026 events

New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial

Medibank funding expansion signals momentum for Emyria’s mental health model

IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending

Chimeric Therapeutics names experienced biotech leader as chair in board and executive refresh

Sign In

Pharmacy will never accept what industry lives with

This is a preview of subscriber content

Latest Video

Most Read

Sussan Ley's sometimes contentious but unquestionably consequential health legacy

PBS spending is driven less by explicit fiscal choices and more by the flow of recommendations

Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines

IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending

'It’s the first time in over 30 years that a new way of administering adrenaline has been approved in Australia'

Follow Us

New Stories

Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines

Director pay rises across ASX healthcare sector, but gender balance remains uneven

Life sciences sector unites to advance women’s leadership at landmark 2026 events

New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial

Medibank funding expansion signals momentum for Emyria’s mental health model

IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending

Chimeric Therapeutics names experienced biotech leader as chair in board and executive refresh